ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,340Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 307

$479K Total Retail Price of All Prescriptions

Rank: 22 out of 307

391 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,812 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 509 398 1 2
LISINOPRIL 471 390 2 3
OMEPRAZOLE 386 231 3 5
LEVOTHYROXINE SODIUM 353 261 4 1
FUROSEMIDE 264 229 5 6
ALENDRONATE SODIUM 240 192 6 20
METOPROLOL SUCCINATE 225 181 7 13
HYDROCODONE-ACETAMINOPHEN 217 99 S3 8 4
AMLODIPINE BESYLATE 210 185 9 7
METFORMIN HCL 179 150 10 8
CITALOPRAM HBR 168 129 11 14
WARFARIN SODIUM 150 136 12 11
LOSARTAN POTASSIUM 127 111 13 16
TAMSULOSIN HCL 122 101 14 21
HYDROCHLOROTHIAZIDE 120 115 15 9
VESICARE 111 93 16 154
ATORVASTATIN CALCIUM 108 97 17 18
CARVEDILOL 106 102 18 24
SPIRONOLACTONE 100 100 19 40
MIRTAZAPINE 91 46 20 51
CHLORTHALIDONE 87 73 21 117
CRESTOR 87 74 21 39
DIGOXIN 85 85 23 36
POLYETHYLENE GLYCOL 3350 84 0 24 50
DIVALPROEX SODIUM 79 0 25 67
POTASSIUM CHLORIDE 77 65 26 10
NEXIUM 77 76 26 38
PHENYTOIN SODIUM EXTENDED 72 40 28 101
ADVAIR DISKUS 71 71 29 28
SPIRIVA 64 63 30 48
FLUOXETINE HCL 64 32 30 32
ALLOPURINOL 63 52 32 27
NORTRIPTYLINE HCL 62 41 33 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 58 34 23
KLOR-CON M20 59 58 35 64
VENTOLIN HFA 58 56 36 98
ACETAMINOPHEN-CODEINE 58 32 S3 36 86
AMITRIPTYLINE HCL 57 22 R 38 65
METOPROLOL TARTRATE 56 52 39 12
TRIAMTERENE-HCTZ 55 55 40 42
ATENOLOL 54 51 41 17
OXYCONTIN 54 39 S2 41 77
TRIAMCINOLONE ACETONIDE 53 45 43 129
BENZTROPINE MESYLATE 53 12 R 43 156
FLUVOXAMINE MALEATE 51 0 45 231
PAROXETINE HCL 51 11 45 43
TRAZODONE HCL 51 27 45 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.